Abstract:Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells, which is a growing field of research that aims to identify biomarkers in cancer immunodiagnosis and to discover innovative cancer immunotherapies.The immune response, including the identification and recognition of cancer-specific antigens, is of particular interest in cancer immunology field as knowledge gained drives the development of new vaccines and antibody therapies. Activation of the immune system for therapeutic benefit against cancer has long been a goal in immunooncology.The passive cancer immunotherapy has been well-established for several decades, and continued advances in antibody and T-cell engineering should further enhance their clinical impact in the years to come. In contrast to these passive immunotherapy strategies, the active cancer immunotherapy has been proved elusive. In the context of advances in the understanding of how tolerance, immunity, and immunosuppression regulate antitumor immune responses together with the advent of targeted therapies, these successes suggest that active immunotherapy represents a path to obtain a durable and long-lasting response in cancer patients. The key to cancer immunodiagnosis and immunotherapy is an improved understanding of the immune response during cancer initiation and progression. According to this background, we have invited investigators to contribute original research articles as well as review articles describing cancer immunodiagnosis and cancer immunotherapy (CICI) and assembled this special issue for updating the recent advances in this field. In this special CICI issue, we have received 23 submitted manuscripts, and 8 manuscripts have been accepted for publication and included in this special issue. For example, a paper of V. Kaewkangsadan et al. has characterized the contribution of T effector/regulatory cells and cytokines to tumor cell death with neoadjuvant chemotherapy (NAC); a paper of L. Qian et al. demonstrated that adoptive cellular immunotherapy (CIT) contributes to improvement of prognosis and inhibition of viral replication in HCV-related HCC patients, without impairment of liver function; a paper of Z. Lu et al. has indicated that p-p70S6K may participate in the invasion and metastasis in the development of esophageal squamous cell carcinoma (ESCC) and downregulation of the expression of p-p70S6K could improve the sensitivity of cells to rapamycin in ESCC; a paper ofM.M. Lotem et al. has discussed the adjuvant autologous melanoma vaccine for macroscopic stage III disease. In addition, four review manuscripts were also included in this special issue. In summary, this special issue covers many important aspects in cancer immunology, including recent advances in the basic and clinical studies relating to cancer immunotherapy. We hope that this special issue can provide valuable information to investigators in the field of CICI and also give the readers a sense of some of the advancements made in this field.

Immuno-Oncology in China

New progress in immunotherapy of lung cancer

Clinical Development of Immuno-Oncology in China

Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing

Cancer Immunology and Cancer Immunodiagnosis

Breast cancer therapy in China: Introducing the Special Collection

Cancer Immunotherapy: an Evolving Paradigm

Navigating the Immune Maze: Pioneering Strategies for Un-shackling Cancer Immunotherapy Resistance

Retrospect and Prospect for Lung Cancer in China: Clinical Advances of Immune Checkpoint Inhibitors.

The Immunotherapy for Colorectal Cancer, Lung Cancer and Pancreatic Cancer

Challenges and Opportunities in Oncology Drug Development and Clinical Research in China

The Current Situation and Trends of Cancer Immunotherapy

Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy

Advances in Clinical and Basic Research for Hepatocellular Carcinoma in China: a 2023 Review

Advances in tumor immunotherapy and gene therapy

Current strategies and prospects of cancer immunotherapy

A Call for Innovative Translational and Clinical Research to Address China's Unique Cancer Landscape

A brand new era of cancer immunotherapy: breakthroughs and challenges

Trends in Oncology Drug Innovation in China

Research advances of traditional Chinese medicine in cancer immunotherapy

Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies